about
DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis.European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG).European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer.Radiation oncologists' view on the zurich consensus.When are breast cancer patients old enough for the quitclaim of local control?Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effects.DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression (MSCC).Target splitting in radiation therapy for lung cancer: further developments and exemplary treatment plans.Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.Amphotericin B lozengers: prophylaxis for esophagitis in thoracic radiotherapy: a prospective study.Clinical and technical characteristics of intraoperative radiotherapy. Analysis of the ISIORT-Europe database.Radiotherapy of testicular intraepithelial neoplasia (TIN): a novel treatment regimen for a rare disease.[Radiation therapy for prostate cancer in the new S3 guideline. Part 2: postoperative radiation therapy and brachytherapy].Analysis of a free-running synchronization artifact correction for MV-imaging with aSi:H flat panels.Intra-operative radiotherapy (IORT) in pancreatic cancer: joint analysis of the ISIORT-Europe experience.DEGRO practical guidelines: radiotherapy of breast cancer II: radiotherapy of non-invasive neoplasia of the breast.DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease.The German S3 guideline prostate cancer: aspects for the radiation oncologist.Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma.NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.Radiotherapy planning for lung cancer: slow CTs allow the drawing of tighter margins.Image quality improvements of electronic portal imaging devices by multi-level gain calibration and temperature correction.Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients.A strategy for the use of image-guided radiotherapy (IGRT) on linear accelerators and its impact on treatment margins for prostate cancer patients.DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy."Augmented reality" in conventional simulation by projection of 3-D structures into 2-D images: a comparison with virtual methods.IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: results of an ISIORT pooled analysis.Irradiation with and without Razoxane in the Treatment of Incompletely Resected or Inoperable Recurrent Rectal CancerCorrigendum to: “European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I” [Eur Urol 2008;53:478–96] and to: “European ConseLumpectomy Plus Tamoxifen or Anastrozole With or Without Whole Breast Irradiation in Women With Favorable Early Breast CancerQuality assurance in breast cancer brachytherapy: geographic miss in the interstitial boost treatment of the tumor bedEndocrine profiles after radiotherapy in stage I seminoma: impact of two different radiation treatment modalitiesExternal beam radiation for prevention of intimal hyperplasia in peripheral arterial bypassesRadiotherapy for lung cancer: target splitting by asymmetric collimation enables reduction of radiation doses to normal tissues and dose escalationQuality assurance in preoperative radiotherapy of rectal cancer: evaluation of a pre-trial dummy-runIntraoperative radiotherapy given as a boost after breast-conserving surgery in breast cancer patientsLocal recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study
P50
Q33529158-C1948179-0FB4-4232-BE36-6E0858867DC5Q34342158-D353D918-8063-47ED-BDCE-4EB7ABF7C998Q34735176-D6A98BCA-6EC7-4983-98B6-0DB56C2B4CBAQ36710620-D5C71DCC-0564-47E1-8AE9-EAA3E2965EFFQ37055475-FC089F4C-4508-413E-8D27-B90474A86439Q37301839-130DD4A1-E507-4CBE-BAFC-FEE7768B3C69Q37573828-21EB1D08-3256-489B-A5E8-013865B90122Q38056081-034548D0-D15C-4782-8FCC-F2E76D7D237CQ38145782-A44EEE9D-4C00-4EF6-AA37-0D8B35EE8900Q39299233-F4247032-E026-4BEF-B75D-545F7E6E0D2FQ43064298-C8A751F3-F293-409F-B463-B80E3FE03793Q43223621-B698176D-85C5-45C3-8C77-949D3626976AQ43299014-6D4E7137-62F4-46CC-9654-9A4BF63EBA8EQ43572060-1E83196E-2824-4A91-BA9F-D26FCB86D1AEQ43655482-D439A828-BF2B-4337-AF84-3E644C57D62BQ44358760-EE36EC4C-0047-4301-B3A4-9B38F3193E1EQ44782942-B4DF0DCC-0FFE-4DF7-A91A-4F1A26637C5EQ45246875-420D2909-F3E2-497A-8834-275CF1261A24Q45890164-8B87BEA3-EA8E-4916-BAFE-9881F6962FC4Q45909385-0E1A4C45-DCC6-4A7D-B132-9DF46FA0E8AFQ46765601-DF54B131-DEE2-4D2F-8741-CEABF7C09183Q46924812-2061244F-F7AF-4B30-ADA2-88AD6D05475FQ47251979-E73F98EB-07D4-4BB2-97D8-FB51871C9219Q47750794-D21FB6AB-2340-4125-8B20-5102EBDE6301Q48931468-50EFC8B5-F62D-424D-89FF-030E653BB043Q50492381-58AEC311-1080-4EF8-82FB-153895AE40B7Q51859125-E773AD51-0BF4-4435-BD84-94C33290233AQ53225060-20E11C7F-D885-4FBE-B4F0-FBD83E0C93CAQ53436484-98664371-CA56-4499-A72D-7D156B86403DQ53441290-68041EB8-EF26-4CDA-BEF2-875D9F220D95Q57095325-8A4E776A-748C-474A-8146-D187A8E51ADFQ57575120-05CB79C9-A417-401F-BA5E-837C05322B7EQ59616807-340B1CBE-B769-4F2C-8AD6-587CF90BB80FQ70997921-16C121ED-CAF3-41F8-9125-11EBF3DC61B9Q73437182-302E08D9-A408-4A95-A8A3-69CEC8FFC20BQ73580715-954DFC4E-2A7D-4146-8CF2-7313A7F95F66Q73665844-9139EACB-99B5-44BF-8C5A-E0E77A728AFBQ74272365-5BE4B43B-1894-496D-9BB9-F7FC4DC9D99EQ74523082-A68A892E-28A6-4E1E-98BA-19151366872EQ75221064-A1B4254F-E2E5-4BF9-9E62-D51C983EB5B2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Felix Sedlmayer
@ast
Felix Sedlmayer
@en
Felix Sedlmayer
@es
Felix Sedlmayer
@nl
Felix Sedlmayer
@sl
type
label
Felix Sedlmayer
@ast
Felix Sedlmayer
@en
Felix Sedlmayer
@es
Felix Sedlmayer
@nl
Felix Sedlmayer
@sl
prefLabel
Felix Sedlmayer
@ast
Felix Sedlmayer
@en
Felix Sedlmayer
@es
Felix Sedlmayer
@nl
Felix Sedlmayer
@sl
P106
P1153
6602450961
P21
P31
P496
0000-0002-1181-0178